Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Oct;28(4):435-41.
doi: 10.1111/j.1365-2125.1989.tb03524.x.

A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2-receptor agonist

G Acton  1 , C Broom
Affiliations
Clinical Trial

A dose rising study of the safety and effects on serum prolactin of SK&F 101468, a novel dopamine D2-receptor agonist

G Acton et al. Br J Clin Pharmacol. 1989 Oct.

Abstract

1. SK&F 101468, a non phenolic indolone derivative, has been characterised preclinically as a novel, potent and specific dopamine D2-receptor agonist. 2. Its tolerability and effects on serum prolactin were investigated in 14 healthy male volunteers in a study of the first administration of SK&F 101468 to man. 3. Doses between 80 micrograms and 2.5 mg caused statistically significant (P less than 0.05) lowering of basal and food stimulated serum prolactin, relative to placebo, over a 6 h post treatment period. 4. SK&F 101468 was well tolerated up to 1 mg with symptoms of nausea and postural hypotension at higher doses.

PubMed Disclaimer

References

    1. Pharmacol Rev. 1985 Jun;37(2):165-216 - PubMed
    1. J Med Chem. 1985 Oct;28(10):1533-6 - PubMed
    1. Eur J Clin Pharmacol. 1987;32(5):457-60 - PubMed
    1. Wien Klin Wochenschr. 1961 Nov 10;73:787-8 - PubMed
    1. Lancet. 1970 Nov 14;2(7681):1014-5 - PubMed

Publication types

LinkOut - more resources